TLIS has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
TLIS has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.
GuruFocus calculates shares buyback ratio using previous shares outstanding minus the current shares outstanding, and then divides by previous shares outstanding. Talis Biomedical's current shares buyback ratio was -1.73%.
The historical data trend for Talis Biomedical's Shares Buyback Ratio % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Talis Biomedical Annual Data | |||||||||||||||
Trend | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||
Shares Buyback Ratio % | Get a 7-Day Free Trial | -94.00 | -350.86 | -34.19 | -1.47 | -1.99 |
Talis Biomedical Quarterly Data | ||||||||||||||||||||
Dec18 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | |
Shares Buyback Ratio % | Get a 7-Day Free Trial | -0.27 | -1.56 | -0.01 | -0.16 | -0.01 |
Talis Biomedical's Shares Buyback Ratio for the fiscal year that ended in Dec. 2023 is calculated as
Shares Buyback Ratio | = | (Shares Outstanding (EOP) (A: Dec. 2022 ) | - | Shares Outstanding (EOP) (A: Dec. 2023 )) | / | Shares Outstanding (EOP) (A: Dec. 2022 ) |
= | (1.78639 | - | 1.82199) | / | 1.78639 | |
= | -1.99% |
Talis Biomedical's Shares Buyback Ratio for the quarter that ended in Mar. 2024 is calculated as
Shares Buyback Ratio | = | (Shares Outstanding (EOP) (A: Dec. 2023 ) | - | Shares Outstanding (EOP) (A: Mar. 2024 )) | / | Shares Outstanding (EOP) (A: Dec. 2023 ) |
= | (1.82199 | - | 1.82215) | / | 1.82199 | |
= | -0.01% |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thank you for viewing the detailed overview of Talis Biomedical's Shares Buyback Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.
Andrew A Lukowiak | officer: President, other: Chief Scientific Officer | 1639 WINDEMERE DRIVE, SAN MARCOS CA 92078 |
Heinrich Dreismann | director | 320 WAKARA WAY, SALT LAKE CITY UT 84108 |
Rebecca Markovich | officer: Interim CFO | CARS.COM INC., 300 S. RIVERSIDE PLAZA, SUITE 1000, CHICAGO IL 60606 |
Raymond Cheong | director | 860 WASHINGTON STREET, 3RD FLOOR, NEW YORK NY 10014 |
Felix Baker | director, 10 percent owner | BAKER BROS. ADVISORS LP, 860 WASHINGTON STREET 3RD FLOOR, NEW YORK NY 10014 |
Baker Bros. Advisors Lp | director, 10 percent owner | 860 WASHINGTON STREET, 3RD FLOOR, NEW YORK NY 10014 |
Julian Baker | director, 10 percent owner | BAKER BROS. ADVISORS LP, 860 WASHINGTON STREET 3RD FLOOR, NEW YORK NY 10014 |
Baker Bros. Advisors (gp) Llc | director, 10 percent owner | 860 WASHINGTON STREET, 3RD FLOOR, NEW YORK NY 10014 |
Baker Brothers Life Sciences Lp | director, 10 percent owner | 860 WASHINGTON STREET, 3RD FLOOR, NEW YORK NY 10014 |
L.p. 667, | director, 10 percent owner | 860 WASHINGTON STREET, 3RD FLOOR, NEW YORK NY 10014 |
Brian J Blaser | director, officer: President and CEO | 561 CIRCLE LANE, LAKE FOREST IL 60045 |
Ramesh Ramakrishnan | officer: Sr. Vice President, R&D | 230 CONSTITUTION DRIVE, MENLO PARK CA 94025 |
Randal W Scott | director | 171 MAIN STREET #225, LOS ALTOS CA 94022 |
Jeryl L Hilleman | director | C/O INTERSECT ENT, INC., 1555 ADAMS DRIVE, MENLO PARK CA 94025 |
Kimberly J Popovits | director | 301 PENOBSCOT DRIVE, REDWOOD CITY CA 94063 |
From GuruFocus
By sperokesalga sperokesalga • 05-11-2023
By GuruFocusNews GuruFocusNews • 03-06-2022
By GuruFocusNews GuruFocusNews • 05-10-2022
By Value_Insider Value_Insider • 11-03-2022
By PRNewswire PRNewswire • 03-07-2022
By GuruFocusNews GuruFocusNews • 03-07-2022
By GuruFocusNews GuruFocusNews • 06-09-2022
By Business Wire • 06-22-2023
By PRNewswire PRNewswire • 03-06-2022
By Marketwired • 07-24-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.